Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I

American Journal of Tropical Medicine and Hygiene

Volumn 72, Issue 2, 2005, Pages 124-125

  Porto, Maria Aurélia F ^a   Alcântara, Lêda M ^a   Leal, Marcelo ^a   Castro, Néviton ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAMBENDAZOLE; IVERMECTIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; INFERTILITY; MALE; PAIN; PERINEUM; SCROTUM DISORDER; SEMEN ANALYSIS; SINGLE DRUG DOSE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; ANIMAL; DIFFERENTIAL DIAGNOSIS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE INFERTILITY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ADULT; ANIMALS; DIAGNOSIS, DIFFERENTIAL; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFERTILITY, MALE; MALE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 15844413839     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.72.124     Document Type: Article

References (13)

1. Newton RC, Limpuangthip P, Grcenherg S, 1992. Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am J Med 92: 202-207.
2. Gotuzzo E, Terashima A, Alvarez H, 1999. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 60: 146-149.
3. Adedayo AO, Grell GA, Bellot P, 2001. Case study: fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 65: 650-651.
4. Satoh M, Futami A, Takahira K, Kodaira M, Tanaka T, Kuriki K, Hori E, 2003. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load. J Infect Chemother 9: 355-357.
5. Neva FA, Oliveira J, Gam AA, 1998. Interferon-γ and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type 1 and Strongyloides stercoralis. J Infect Dis 178: 1856-1859.
6. Porto MAF, Neva FA, Lisboa W, Thompson R, Alcântara L, Carvalho EM, 2001. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 23: 503-507.
7. Porto MAF, Oliveira Filho J, Neva FA, Orge G, Alcântara L, Gam A, Carvalho EM, 2001. Influence of HTLV-1 infection on serologic and skin tests for strongyloidiasis. Am J Trop Med Hyg 65: 610-613.
8. Morimoto J, Kaneoka H, Snsatomi Y, Sato YN, Murata T, Ogahara S, Sakata N, 2002. Disseminated strongyloidiasis in nephrotic syndrome. Clin Nephrol 57: 398-401.
9. Lenios LB, Qu Z, Laucirica R, Fred HL, 2003. Hyperinfection syndrome in strongyloidiasis: report of two cases. Ann Daign Pathol 7: 87-94.
10. O'Doherty MJ, van de Pelle JE, Nunan TO, Croft DN, 1984. Recurrent Strongyloides stercoralis infection in a patient with T-cell lymphoma-leukaemia. Lancet 1: 858.
11. Phelps KR, Ginsberg SS, Cinningham AW, Tschachler E, Dosik H, 1991. Case report: adult T-cell leukemia/lymphoma associated with recurrent Strongyloides hyperinfection. Am J Med Sci 302: 224-228.
12. Patey O, Gessain A, Breuil J, Courillon-Mallet A, Daniel MT, Miclea JM, Roucayrol AM, Sigaux F, Lafaix C, 1992. Seven years of recurrent severe strongyloidiasis in an HTLV-1-infected man who developed adult T-cell leukaemia. AIDS 6: 575-579.
13. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K, 2002. Reduced efficacy of treatment of strongyloidiasis in HTLV-1 carriers related to enhanced expression of IFN-γ and TGF-β1. Clin Exp Immunol 127: 354-359.